Kamada Ltd risk profile

29 Normal where most of the sector sits

Measured 1 September 2026 from KMDA's filed statements. Recomputed nightly.

29 (Normal), driven by Market expectation at 37, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation37NormalStableOne-year price volatility — 33.8%
Operating pressure24NormalWorseningCosts outgrowing revenue — -2.7 percentage points
Cash conversion37NormalWorseningCapital spending against operating cash — 0.39x
Leverage and coverage2ContainedStableCurrent ratio — 4.07x
Competitive position36NormalStableR&D-intensity gap against peers — -21.7 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Kamada Ltd